← All stories
● Covered by 1 source · 1 reportMedium impact1 negative

NHS Trusts Report Limited Use of Palantir AI Platform Despite Official Claims

🔄 Updated 4d ago
New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • 29 NHS trusts listed as benefiting from Palantir's FDP report limited or no use.
  • NHS England claims 137 trusts are "live" with the FDP.
  • The Office for Statistics Regulation is investigating the claims.
  • The contract is valued at £330 million.

Discrepancy in Palantir FDP Usage

More than two dozen hospital trusts, specifically 29, that NHS England publicly lists as "realising benefits" from Palantir's £330m federated data platform (FDP) are reportedly not using all or most of the AI-powered technology. These trusts have stated that the system is either not live or they are not using any of its applications, contradicting NHS England's claims.

Official Claims vs. Trust Reports

NHS England's website indicates that 137 trusts are "live" with the FDP. However, freedom of information requests revealed that 29 of the trusts described as "realising benefits" responded that they were not using the system or its applications. Examples include Epsom and St Helier, Kent and Medway, Mersey Care, and Nottingham University Hospitals, all stating the FDP is not currently live or in use.

Scrutiny and Investigation

This apparent gap between NHS claims and the trusts' understanding has been described as "very misleading" by a senior health official. The Office for Statistics Regulation (OSR) is now investigating these claims under its casework function. Previously, NHS England faced scrutiny over data used to defend the Palantir contract, including a claim of 117,539 more operations carried out by trusts using the FDP, which it later conceded could not be proven as cause and effect.

Calls for Contract Termination

The health secretary, Yvette Cooper, is facing calls from MPs and campaigners to terminate the US tech firm's contract. Palantir's UK and Europe chief executive, Louis Mosley, has defended the contract, stating that ending it would be "putting politics above patients" and accusing critics of "Palantir Derangement Syndrome."

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~4 min · 3 stories · Nov 07

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

Reporting from

Twenty-nine NHS hospital trusts listed by NHS England as "realising benefits" from Palantir's £330m federated data platform (FDP) are not fully utilizing the AI technology, with some reporting it is not live or they are not using its applications. This discrepancy between official claims and actual usage has led to calls for the contract to be axed and an investigation by the Office for Statistics Regulation.